Studying tumor tissue from extramedullary myeloma
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial collects stored tissue samples from people with multiple myeloma that has spread outside the bone marrow. The goal is to study these samples to learn more about the disease and possibly find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older).
- You must have a confirmed diagnosis of multiple myeloma that has spread outside the bone marrow (extramedullary myeloma).
- You must have a stored tissue sample (FFPE block) from a surgery that is available for testing.
- Your diagnosis must have been made within the past 10 years.
- Your medical records and follow-up information must be available for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies tissue samples from people with a specific genetic change in their myeloma cells. It aims to better understand this type of myeloma to improve future treatment.
This trial studies myeloma (and closely related blood disorders) by using extra blood or bone marrow samples for lab research. It aims to help discover new ways to understand or treat myeloma.
This study is collecting blood samples from people with plasma cell disorders to help researchers learn more about these conditions. It may be a good fit if you haven't started treatment yet and are willing to donate samples.
This study looks at how multiple myeloma (a bone marrow cancer) changes over time, especially why it becomes resistant to treatment or comes back. It may help researchers learn what drives relapse and could lead to better future treatments.
This is an observational study that follows people with early blood findings that can be linked to multiple myeloma, to understand what happens over time. It does not test a new drug for most people; instead, it tracks health, lab results, and imaging to learn who may develop myeloma.
This is a study that collects information from people diagnosed with multiple myeloma. It may help researchers understand the disease and improve future care by using past and ongoing patient data.
Hear when a new Multiple Myeloma and Malignant Plasma Cell Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.